3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia
14
Multiple Myeloma
12
Lymphoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Hodgkin Disease
11
Lymphoma, Non-Hodgkin
10
Leukemia, Myeloid, Chronic-Phase
8
Primary Myelofibrosis
7
Neoplasms, Plasma Cell
7
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myelomonocytic, Chronic
7
Congenital Abnormalities
7
Lymphoma, Follicular
6
Leukemia, Myeloid, Accelerated Phase
6
Hematologic Neoplasms
6
Blast Crisis
6
Sezary Syndrome
5
Mycosis Fungoides
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, T-Cell, Cutaneous
4
Interventions
apixaban
1
Tacrolimus
1
Gemcitabine
1
Fondaparinux
1
Drug Therapy
1
Cyclosporine
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Venous Thromboembolism
×
Tacrolimus
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled